Role of the liver in the prevention of indomethacin-induced intestinal ulcers by spironolactone.
D000818:Animals; D004097:Dihydrotachysterol; D004336:Drug Antagonism; D004790:Enzyme Induction; D005260:Female; D006498:Hepatectomy; D007213:Indomethacin; D007410:Intestinal Diseases / Q000139:chemically induced* / Q000517:prevention & control*; D007416:Intestinal Perforation / Q000139:chemically induced; D008099:Liver / Q000502:physiology*; D008297:Male; D008862:Microsomes, Liver; D051381:Rats; D013148:Spironolactone / Q000494:pharmacology / Q000627:therapeutic use*; D013268:Stimulation, Chemical; D014456:Ulcer / Q000139:chemically induced / Q000517:prevention & control
D013148:Spironolactone; D004097:Dihydrotachysterol; D007213:Indomethacin